Journal Watch · eLife · 2026

Cryo-EM structure revealed a novel F-actin binding motif in a <i>Legionella pneumophila</i> lysine fatty acyltransferase.

These findings establish a foundation for studying the KFAT family of bacterial toxins and uncover a novel F-actin-binding motif, providing an alternative F-actin marker with notable flexibility.

Zeng WW, Komaniecki G, Liu J et al.eLife3 min readPharma relevance 40/100

DOI: 10.7554/elife.106975PMID: 41604247Study type: research study

TL;DR

These findings establish a foundation for studying the KFAT family of bacterial toxins and uncover a novel F-actin-binding motif, providing an alternative F-actin marker with notable flexibility.

Key findings

  • Furthermore, we demonstrated that Lfat1 exhibits lysine fatty acyltransferase (KFAT) activity, targeting host small GTPases.
  • These findings establish a foundation for studying the KFAT family of bacterial toxins and uncover a novel F-actin-binding motif, providing an alternative F-actin marker with notable flexibility.

What they did

Lfat1 specifically binds F-actin through a novel actin-binding domain (ABD). High-resolution cryo-electron microscopy (Cryo-EM) analysis revealed that this ABD forms a long α-helix hairpin, with its tip interacting with subdomains I and II of two adjacent actin molecules within the F-actin filament. Interestingly, while individual α-helices of the hairpin fail to bind F-actin, co-expression as separate fusion proteins restores binding activity.

Full abstract (original)

Background: <i>Legionella pneumophila</i> is an opportunistic bacterial pathogen that causes Legionnaires' disease. To establish an intracellular niche conducive to replication, <i>L. pneumophila</i> translocates a diverse array of effector proteins that manipulate various host cellular processes, including the actin cytoskeleton. In a screen for effectors that alter actin dynamics, we identified a <i>Legionella</i> effector, Lfat1 (lpg1387), which colocalizes with the actin cytoskeleton in eukaryotic cells.

What they did: Lfat1 specifically binds F-actin through a novel actin-binding domain (ABD). High-resolution cryo-electron microscopy (Cryo-EM) analysis revealed that this ABD forms a long α-helix hairpin, with its tip interacting with subdomains I and II of two adjacent actin molecules within the F-actin filament. Interestingly, while individual α-helices of the hairpin fail to bind F-actin, co-expression as separate fusion proteins restores binding activity.

Results & conclusions: Furthermore, we demonstrated that Lfat1 exhibits lysine fatty acyltransferase (KFAT) activity, targeting host small GTPases. These findings establish a foundation for studying the KFAT family of bacterial toxins and uncover a novel F-actin-binding motif, providing an alternative F-actin marker with notable flexibility.

Abstract © the authors / eLife (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.7554/elife.106975 · PubMed 41604247.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking eLife for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this eLife study find?

These findings establish a foundation for studying the KFAT family of bacterial toxins and uncover a novel F-actin-binding motif, providing an alternative F-actin marker with notable flexibility.

What type of study is this?

It is a research study, published in eLife in 2026. Lfat1 specifically binds F-actin through a novel actin-binding domain (ABD).

Where can I read the original paper?

The original is at the publisher via DOI 10.7554/elife.106975. PubMed ID: 41604247. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Zeng WW, Komaniecki G, Liu J et al.. Cryo-EM structure revealed a novel F-actin binding motif in a &lt;i&gt;Legionella pneumophila&lt;/i&gt; lysine fatty acyltransferase.. eLife (2026). DOI: 10.7554/elife.106975.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/cryo-em-structure-revealed-a-novel-f-actin-binding-motif-in-a-lt-i-gt-le-106975/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides